Literature DB >> 18041653

Reactive oxygen species and human platelet GP IIb/IIIa receptor activation.

John C Sill1, Jacqueline A Proper, Michael E Johnson, Cindy B Uhl, Zvonimir S Katusic.   

Abstract

This study concerned reactive oxygen species for their potential to activate human platelet GP IIb/IIIa receptors. All cells produce reactive oxygen species - radicals that can abstract electrons and hydrogen atoms from biological molecules to alter cell function. In many cells, radicals contribute to cellular signaling. In platelets, the predominant oxidant effect is platelet activation. Less is known concerning oxidants and GP IIb/IIIa receptor activation. The first aim of the current study was to confirm that although both H(2)O(2) and tert butyl hydroperoxide both predispose platelets to aggregation; neither directly activates GP IIb/IIIa receptors. The second aim was to demonstrate that even in the presence of extracellular redox iron; H(2)O(2) does not activate GP IIb/IIIa receptors. The third aim was to determine if extracellular superoxide anions evoke GP IIb/IIIa activation. Finally, a role for intra-platelet iron in GP IIb/IIIa activation was examined. Intracellular superoxide anions are produced in excess during platelet activation and curiously, they are uniquely able to increase intracellular free iron. This iron can, in a redox manner, generate radicals and these iron dependent species modulate signaling systems, including systems associated with adhesion receptor activation. In the current studies, platelets in suspension were exposed to H(2)O(2) and to tert butyl hydroperoxide, to H(2)O(2) plus ferrous or ferric chloride (+/- ascorbate to enhance iron redox cycling) and to xanthine plus xanthine oxidase to generate extra-platelet superoxide anions. Intra-platelet iron was increased with iron ionophore 8-hydroxyquinoline. During flow cytometry, intra-platelet oxidant state was assessed with the redox sensitive fluorescent indicator H2DCF, while GP IIb/IIIa activation was assessed using fluorescent antibody PAC-1. Results showed that although all the oxidizing systems examined increased intra-platelet oxidant state, GP IIb/IIIa receptors were not activated by H(2)O(2), by tert butyl hydroperoxide, by H(2)O(2) plus iron (+/- ascorbate) or by xanthine plus xanthine oxidase. In contrast, iron plus ionophore 8-hydroxyquinoline evoked GP IIb/IIIa activation. Platelet positivity for PAC-1 increased from 2 +/- 0.2 to 28 +/- 7% (P < 0.005). However this response, although vigorous, was less than 56 +/- 8% (P < 0.001) evoked by thrombin 0.1 milliunit/ml. In conclusion, the results indicated that oxidant systems external to platelets did not activate GP IIb/IIIa receptors while increased intra-platelet iron was associated with appearance of cytosolic oxidizing species and with GP IIb/IIIa receptor activation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18041653     DOI: 10.1080/09537100701481385

Source DB:  PubMed          Journal:  Platelets        ISSN: 0953-7104            Impact factor:   3.862


  8 in total

1.  Glutathione peroxidase-3 deficiency promotes platelet-dependent thrombosis in vivo.

Authors:  Richard C Jin; Christopher E Mahoney; Laura Coleman Anderson; Filomena Ottaviano; Kevin Croce; Jane A Leopold; Ying-Yi Zhang; Shiow-Shih Tang; Diane E Handy; Joseph Loscalzo
Journal:  Circulation       Date:  2011-04-25       Impact factor: 29.690

2.  Phospholipase C-γ2 via p38 and ERK1/2 MAP kinase mediates diperoxovanadate-asparagine induced human platelet aggregation and sCD40L release.

Authors:  Ankita Misra; Smriti Srivastava; Seshadri Reddy Ankireddy; Nashreen S Islam; Tulika Chandra; Ashutosh Kumar; Manoj Kumar Barthwal; Madhu Dikshit
Journal:  Redox Rep       Date:  2013-07-23       Impact factor: 4.412

3.  Oxygen therapy for sepsis and prevention of complications.

Authors:  Hayk Minasyan
Journal:  Acute Crit Care       Date:  2022-03-17

4.  Hemolysate-mediated platelet aggregation: an additional risk mechanism contributing to thrombosis of continuous flow ventricular assist devices.

Authors:  Phat L Tran; Maria-Grazia Pietropaolo; Lorenzo Valerio; William Brengle; Raymond K Wong; Toshinobu Kazui; Zain I Khalpey; Alberto Redaelli; Jawaad Sheriff; Danny Bluestein; Marvin J Slepian
Journal:  Perfusion       Date:  2015-11-20       Impact factor: 1.972

5.  The activity of antioxidant enzymes in blood platelets in different types of renal replacement therapy: a cross-sectional study.

Authors:  Joanna Stępniewska; Barbara Dołęgowska; Elżbieta Cecerska-Heryć; Edyta Gołembiewska; Alicja Malinowska-Jędraszczyk; Małgorzata Marchelek-Myśliwiec; Kazimierz Ciechanowski
Journal:  Int Urol Nephrol       Date:  2016-01-21       Impact factor: 2.370

6.  The effect of reactive oxygen species on whole blood aggregation and the endothelial cell-platelet interaction in patients with coronary heart disease.

Authors:  Jonathan Watt; Marie-Ann Ewart; Fiona H Greig; Keith G Oldroyd; Roger M Wadsworth; Simon Kennedy
Journal:  Thromb Res       Date:  2012-04-19       Impact factor: 3.944

7.  Secretory phospholipase A2 modified HDL rapidly and potently suppresses platelet activation.

Authors:  Sanja Curcic; Michael Holzer; Lisa Pasterk; Eva Knuplez; Thomas O Eichmann; Saša Frank; Robert Zimmermann; Rudolf Schicho; Akos Heinemann; Gunther Marsche
Journal:  Sci Rep       Date:  2017-08-14       Impact factor: 4.379

8.  The role of Nox1 and Nox2 in GPVI-dependent platelet activation and thrombus formation.

Authors:  T G Walsh; M C Berndt; N Carrim; J Cowman; D Kenny; P Metharom
Journal:  Redox Biol       Date:  2014-01-13       Impact factor: 11.799

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.